Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Amanda Bronstad | May 4, 2017
A federal jury in New Orleans deliberated for less than two hours before coming back this week with a defense win in the first bellwether trial over the blood thinner Xarelto. That's a bona fide slam dunk--even for lead defense counsel Beth Wilkinson, who's notched a streak of trial victories in her career.
1 minute read
By Jason Grant | May 4, 2017
New York University's breach of contract lawsuit against Pfizer over hundreds of millions of dollars in cancer drug royalties must go forward, a divided Manhattan appeals court has ruled.
1 minute read
By Charles Toutant | May 3, 2017
AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
1 minute read
By Amanda Bronstad | May 3, 2017
Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
1 minute read
By Charles Toutant | May 2, 2017
A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
1 minute read
By P.J. D'Annunzio | May 2, 2017
A group of 485 independently owned pharmacies nationwide has sued OptumRx, the successor company to Catamaran Corp. through a merger, claiming they were low-balled on reimbursements based on outdated pricing data.
1 minute read
By Max Mitchell | May 1, 2017
Three weeks before the latest Risperdal case was tossed out midtrial, one of the jurors initially tasked with evaluating the claims collapsed while a plaintiff's expert was testifying on the stand.
1 minute read
By Scott Graham | May 1, 2017
The U.S. Court of Appeals for the Federal Circuit ruled a drug used to treat chemotherapy symptoms did not avoid the on-sale bar for patents despite keeping some details of its drug sale confidential.
1 minute read
By Jason Grant | May 1, 2017
A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
1 minute read
By P.J. D'Annunzio | May 1, 2017
There will be no second chance for a dismissed False Claims Act case pursued by a whistleblower and numerous government entities alleging that Genentech suppressed data about Avastin, a federal appeals court has decided.
1 minute read
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
East Brunswick Law firm concentrating in plaintiff's personal injury, employment law, medical malpractice and worker's compensation seeks an...
State of New Jersey COMMISSION OF INVESTIGATION 50 WEST STATE STREET PO Box - 045 TRENTON, NEW JERSEY 08625-0045 Telephone (609) 292-6767 Fa...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS